Consensus TriSalus Life Sciences, Inc.

Equities

End-of-day quote Nasdaq Other stock markets 06:00:00 2024-05-27 pm EDT			5-day change	1st Jan Change
7.9 ^USD	+4.50%		+4.50%	-6.51%

May. 30	Canaccord Genuity Initiates TriSalus Life Sciences at Buy Rating With $12 Price Target	MT
May. 30	Canaccord Genuity Starts Coverage on TriSalus Life Sciences With Buy Rating, $12 Price Target	MT

b90436076.yDetciqLOmXooLYHxande1K1It7gmlU73rxWKxPR-yI.gnP6FlvDVTa9y_pSjtuUEDSEGpm6ywdr59QVaiHnnE-CVvggHcBpFprwgg~c24c4243ea3f4a9f6a8e8409a3e2b08c

Canaccord Genuity Initiates TriSalus Life Sciences at Buy Rating With $12 Price Target	May. 30	MT
Canaccord Genuity Starts Coverage on TriSalus Life Sciences With Buy Rating, $12 Price Target	May. 30	MT
TriSalus Life Sciences Launches Warrant Exchange Offer	May. 24	MT